# Bausch Health

Source: https://onco.cc/companies/bausch-health/  
OnCo record `bausch-health` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Bausch Health (formerly Valeant) is a diversified pharmaceutical company whose oncology-adjacent products include the retinoid bexarotene (Targretin) and imiquimod (Zyclara) for actinic keratosis.

## Summary

Bausch Health sells dermatology, gastroenterology, eye health (Bausch + Lomb) and generic medicines. In oncology it holds the US applications for Targretin (bexarotene) in cutaneous T-cell lymphoma and Zyclara and Aldara (imiquimod), the latter approved for superficial basal cell carcinoma and actinic keratosis.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- HQ: Laval, Quebec
- Type: pharma
- Website: https://www.bauschhealth.com
- Ticker: BHC

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/Bausch_Health
- Official website: https://www.bauschhealth.com

## Connected records

- drugs: [Bexarotene](https://onco.cc/drugs/bexarotene/), [Imiquimod](https://onco.cc/drugs/imiquimod/), [Methylnaltrexone](https://onco.cc/drugs/methylnaltrexone/)
- trials: [MNTX 302](https://onco.cc/trials/mntx-302/)
- key papers: [Methylnaltrexone for opioid-induced constipation in advanced illness (MNTX 302)](https://onco.cc/key-papers/paper-mntx-302-thomas-nejm-2008/)

---
JSON: https://onco.cc/api/v1/entities/bausch-health.json